A seven-year-old Class 2 student, Madivi Jamuna, has died after falling ill following the distribution of chloroquine tablets during a malaria-prevention drive in Gollaguppa village in Andhra Pradesh’s Polavaram district. Officials said 71 residents were given the tablets after malaria cases were detected in the area, following which several people reported symptoms and were taken for treatment.
The latest official update said 29 patients were being treated at Bhadrachalam Area Hospital in neighbouring Telangana, while 24 were receiving care at Lakshmipuram Primary Health Centre. The Andhra Pradesh government has deployed specialist medical teams, including paediatricians, and set up a medical camp in the village.
Chief Minister N Chandrababu Naidu has ordered a comprehensive inquiry and directed officials to ensure the best possible treatment for those affected. District Collector K Dinesh Kumar said the condition of the patients under treatment was stable and urged residents not to panic. Authorities have not yet established that chloroquine caused Jamuna’s death, and the exact cause remains under investigation.
Child’s Death Triggers Probe
The incident unfolded in Gollaguppa, a remote tribal village in Yetapaka mandal, after health officials conducted fever surveillance and malaria-prevention activities following reports of malaria cases. According to the district administration, 71 people were administered chloroquine tablets as part of the preventive effort. Soon afterwards, several residents, including children, began reporting symptoms such as vomiting and other forms of discomfort, prompting their families to seek medical assistance.
Jamuna, a Class 2 student at the local government school, was among those who fell ill. Reports said she developed vomiting after returning home and was taken for medical treatment before being shifted to Bhadrachalam Area Hospital for further care. She subsequently died during treatment. Her death has become a central part of the investigation, with authorities yet to determine whether the medicine was directly responsible.
The scale of the incident has also resulted in varying figures in early reports. The district administration’s latest account states that 29 patients were being treated at Bhadrachalam Area Hospital and another 24 at Lakshmipuram PHC, taking the number receiving treatment to 53. Other reports have cited 52 patients or different numbers at individual facilities, partly reflecting transfers as patients moved between healthcare centres.
The incident has raised concerns because of the difficulties faced by residents in accessing emergency healthcare. Reports said the remote location made it difficult for ambulances to reach the village, with some parents reportedly taking sick children by tractors and motorcycles to Bandirevu, a nearby junction, before they were moved to medical facilities.
Doctors Examine Possible Causes
While the timing of the illness has prompted questions about the chloroquine tablets, officials have cautioned against drawing conclusions before the investigation is complete. District Collector K Dinesh Kumar said the tablets were administered according to prescribed age-based dosages.
He also said quality-control tests of the medicine had produced satisfactory results. However, the specific batch administered in Gollaguppa has been sent to the Visakhapatnam forensic laboratory for further analysis.
Jamuna’s medical history is also being examined. According to Hindustan Times, officials are looking into the possibility of an underlying medical condition after learning that two other children in her family, both below one year old, had previously died from unidentified causes.
Doctors are reportedly examining whether a possible genetic cardiac condition could have contributed to her death and whether chloroquine may have triggered a cardiac complication in a person with such a condition. This remains a possibility being investigated and is not an established explanation for her death.
Authorities have simultaneously stepped up medical surveillance in Gollaguppa. A nine-member specialist team from Kakinada Government General Hospital has reached the area, while additional teams from Vijayawada, Rajamahendravaram and Kakinada have been deployed. Three paediatricians are also part of the response, with a dedicated medical camp established in the village to screen residents and monitor anyone who develops symptoms.
The administration is also undertaking wider health assessments among villagers. The Indian Express reported that officials were preparing health profiles for around 270 residents, including screening for conditions such as sickle-cell anaemia and other health problems.
The response comes amid conflicting claims circulating online. Some social-media posts and reports have alleged additional deaths or problems with the medicines, but these claims have not been confirmed by the district administration.
The latest official information confirms one death and says the other patients receiving treatment are stable. In a situation involving children and a remote community, distinguishing verified information from speculation remains especially important.
The Logical Indian’s Perspective
The death of a seven-year-old child following a public-health intervention is a deeply distressing incident, regardless of what the final investigation establishes as the medical cause. Malaria prevention is essential, particularly in vulnerable and remote communities, but public-health measures must also be accompanied by rigorous safety checks, transparent communication and rapid access to medical care.
The priority now should be to ensure that every affected patient receives timely and compassionate treatment, while the investigation establishes what went wrong, if anything, without rushing to conclusions or allowing rumours to deepen public fear. The government must also communicate its findings openly with the affected families and community so that trust in essential healthcare programmes is not damaged.
Also read: Tukaram Mundhe’s Loose Oil Crackdown Put On Hold; Fadnavis Grants Traders One-Year Compliance Window
